Oncothyreon to present at Rodman & Renshaw Global Healthcare Conference
SEATTLE, WA, Sep. 3, 2009 (Canada NewsWire via COMTEX News Network) -- Oncothyreon Inc. (Nasdaq: ONTY) (TSX: ONY) announced today that Robert Kirkman, M.D., President and Chief Executive Officer, will present at the Rodman & Renshaw 11th Annual Healthcare Conference taking place Sept. 9-11, 2009 in New York.
Dr. Kirkman will present at 2 p.m. Eastern Time on Thursday, Sept. 10. A live and archived webcast of the presentation will be accessible at http://www.wsw.com/webcast/rrshq15/onty or by visiting the Oncothyreon website www.oncothyreon.com under the "News & Events" section.
About Oncothyreon
Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit www.oncothyreon.com.
SOURCE: Oncothyreon Inc.
Investor and Media Relations Contact: Julie Rathbun, Rathbun Communications, (206) 769-9219, ir@oncothyreon.com
Copyright (C) 2009 CNW Group. All rights reserved.
News Provided by COMTEX